Hepatology Webinars 2021|Hepatology online Events|Hepatitis meetings|Hepatology Congress|Liver Conferences|Liver webinars|Gastroenterology webinars |Hepatology Conferences |Gastro meetings|Hepatitis summit|Digestive meetings|Top Hepatology webinars|Top Hepatology conferences|Europe | Asia-pacific|USA

Theme: Recent advances in the Field of Hepatology & Gastroenterology

HEPATOLOGY-2021

HEPATOLOGY-2021

Conference Series LLC LTD cordially welcomes you all to attend the “7^th International conference on Hepatology” which scheduled on June 14-15, 2021. The main objective of the conference is to bring together leading Academicians, scientists, Researchers, Graduate students and Business delegates from the field of medical Gastroentrologists, Hepatologists, Nephroligists, Pathologists, Virologists, Oncologists,pharmaceutical specialists and others from all over the world

Hepatology-2021 is a two days Webinar organized by Organizing Committee Members where it starts with a keynote session followed by oral presentation and poster presentations and final ends with the certificate distribution.

7^th International conference on Hepatology unites specialists, researchers, analysts, teachers and students with an intend to give an intelligent sessions and universal stage to trade and share their works and thoughts in creating field of Pancreas, liver, Gallbladder, stomach, Pharnyx, Endoscopic, Esophagus and intestinal Diseases etc.

Scope of the Conference

Hepatology 2021 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range of topics and allow participants to discuss about the management of liver diseases. Hepatology 2019 conference consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters will be judged and awarded during the conference. To encourage broad participation from all over the world Conference Series Ltd is offering reduced registration fee for students.

Attending Hepatology-2021 is different to everyone. The 5 key benefits of attending Hepatology-2021 are

Meet the experts & influencers
Learning in a new space
Networking opportunities
Expand your knowledge
Again Collaborations

PRESENTATION REQUIREMENTS:

Participating authors are answerable for registration, travel, and hotel costs. Note: Those with submitted abstracts will get an acknowledgment mail enabling them to enrol for the gathering.

Abstracts will be compiled, and conference books are made available to participants at the conference.

Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

SUBMISSION OPTIONS:

Oral paper introductions will have 30-minute schedule time slot. The keynote session will have for 45-minute presentation duration, workshop/special session will have 1-hour long schedule opening and symposium will have 1-hour long availability followed by 5-minute Q&A session.

Graduate and master’s understudies are qualified to present their abstracts under poster and e-poster presentation category.

Ph.D. understudies are qualified to submit their abstract under special YRF (Young Researcher's Forum), poster and e-poster presentation category.

NOTE: YRF category includes short oral presentation especially for Ph. D. students

Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

Track 1: Hepatitis and Liver Diseases

Liver diseases can be gained (innate) or achieved by a collection of parts that hurt the liver, for instance, as contaminations and liquor use. Weight is likewise connected with liver harm. After some time, mischief to the liver achieves scarring (cirrhosis), which can prompt liver disappointment, a perilous condition. Hepatitis happens because of the inflammation in tissues of liver caused because of viral contamination which can hurt the organ which may additionally prompts cirrhosis, fibrosis and liver malignant growth. Hepatitis is an overwhelming that progress gradually yet brings about harm of the liver.

USA: American Gastroenterological Association, Canadian Association of Gastroenterology, North Carolina Society of Gastroenterology, Canadian Society of Gastroenterology Nurses and Associates, Florida Gastroenterological Society, Ontario Association of Gastroenterology, Alabama Gastroenterological Society, Comparative Gastroenterology Society, American Neuro-gastroenterology and Motility Society.

Europe: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Pediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology, British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Asia-Pacific: Gastroenterological Society of Australia, Gastroenterological Association of Thailand (GAT), Indian Society of Gastroenterology, Philippine Society of Gastroenterology, Society for Gastroenterology & Hepatology in Nigeria, Gastroenterological Society of Taiwan.

Track 2: Hepatitis B

Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). HBV is transmitted through activities that involve percutaneous or mucosal contact with infectious blood or body fluids. HBV can survive outside the body at least 7 days and still be capable of causing infection. The best way to prevent hepatitis B is by getting the hepatitis B vaccine. The pathogenesis and clinical manifestations of hepatitis B are due to the interaction of the virus and the host immune system, which lead to liver injury and potentially cirrhosis and hepatocellular carcinoma. Patients can have either an acute symptomatic disease or an asymptomatic disease.

Track 3: Hepatitis C

Hepatitis C is a devastating liver disease caused by Hepatitis C virus (HCV) which causes acute and chronic infection. In some cases, chronic hepatitis often leads to liver cancer or cirrhosis. Chronic Hepatitis causes liver damage and fibrosis, hepatomegaly, hepatocellular carcinoma.

HCV is a bloodborne virus transmitted due intravenous drug use, unsterilized medical equipment, from mother to baby during birth, sexual contact with infected person. HCV virus has no vaccine; therefore, prevention of virus prevalence is recommended.

Track 4: Gastroenterology

Gastroenterology is the study of detailed understanding of the physiology of the gastrointestinal organs including the movement of material through the stomach and intestine the digestion and absorption of nutrients into the body, removal of waste from the system, and the function of the liver as a digestive organ.

Track 5: Pancreas

Pancreas being a very close part to the liver helps to regulate sugar level in the body and also helps in many other functions. It is this part of the body that extremely helps in regulation of glucose level in the body.

Track 6: Hepatitis Vaccination

The best way to prevent hepatitis is by getting the hepatitis vaccines. Vaccination is safe and effective, and it is recommended for all. Efforts to develop a hepatitis C vaccine started more than 20 years ago, when the hepatitis C virus was identified. The hepatitis C virus is more variable than are the viruses that cause hepatitis A and hepatitis B. Hepatitis C virus occurs in at least six genetically distinct forms with 50 subtypes. A global vaccine would have to protect against all these variants of the virus.

Track 7: Liver and Biliary

The liver is the largest gland in the body and conducts a myriad of vital metabolic and excretory functions. In addition, by virtue of its circulatory relationship to the absorptive surface of the gastrointestinal tract, the liver is the initial site where ingested nutrients, and other substances entering via the gastrointestinal tract, such as drugs and bacterial metabolites, are processed by the body. Thus, the liver is a gatekeeper that can process useful substances while detoxifying orally absorbed substances that are potentially harmful, such as toxic xenobiotics.

Track 8: Liver Diseases

Liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women, and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).

Track 9: Liver Diseases Diagnosis

Screening for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status.

Track 10:Inflammatory Bowel disease

Inflammatory Bowel Disease(IBD) is an idiopathic disease caused by a dysregulated resistant reaction to have intestinal microflora. The two major types of Inflammatory Bowel Disease are ulcerative colitis (UC), which is confined to the colonic mucosa, and Crohn’s diseases (CD), which can impact any system of the gastrointestinal tract from the mouth to the butt, incorporates "skip sores," and is transmural. There is a hereditary inclination for IBD, and patients with this condition are more inclined to the development of malignancy.

11.Gastrointestinal Radiology and Imaging

Gastrointestinal Radiology or GI Imaging utilizes a state of constant x-beam called fluoroscopy and a barium-based separate texture to make photos of the stomach, throat, digestive tract and other parts of stomach related structure. It is secure, non-invasive, and may be habituated to benefit absolutely destructive reflux, analyze torment, blood in the stool & other side effects. Computed tomography now permits the comprehensive assessment of abdominal and pelvic inflammatory and infectious processes, obstruction, tumor identification and staging, and show of vasculature and obtuse injury impacts. Barium studies of the gastrointestinal tract, enteroclysis for small-bowel assessment, and conventional radiography still have a role, regardless of the broad utilization of fibreoptic endoscopy. Fluoroscopy is as yet significant; however extraordinary advances in innovations have changed gastrointestinal radiology unavoidably

Track 12: Herbal Medicines for Liver diseases

The use of herbal products as medications has its origin thousands of years ago. In Western countries, herbal medicine products are gaining increasing popularity. Some herbal products may potentially benefit people with liver disease.

Track 13: Pregnancy and Liver Diseases

Several disorders contribute to liver disease in pregnancy such as acute fatty liver of pregnancy (AFLP) and intrahepatic cholestasis of pregnancy (IHCP), hyperemesis gravidarum and hemolysis and elevated liver enzymes and low platelets (HELLP) syndrome. Liver disease such as acute viral hepatitis can occur in pregnancy and pregnancy may occur in a patient with underlying chronic liver disease including patients with cirrhosis and portal hypertension, and patients who have undergone liver transplantation.

Track 14: Non-Viral Hepatitis

Non-viral hepatitis is an inflammation of the liver caused by toxins, drugs, or other harmful chemicals that destroy cells in the liver (Hepatocytes). Acute hepatitis damages hepatocytes make up 70-85% of the total mass of the liver. The disease is a growing problem due to the increasing number of dietary supplements with liver side effects. If hepatitis leads to liver failure, a liver transplant is the only treatment option that can improve survival.

Track 15: Liver Transplantation and Surgery

Liver transplantation surgery technique to replace a diseased or injured liver with a healthy liver delivered from a healthy person. The liver is involved in various metabolic functioning including metabolism of drugs and toxins, removing degradation products of normal body metabolism (for example clearance of ammonia and bilirubin from the blood), and synthesis of many important proteins and enzymes (such as factors necessary for blood to clot). Doctors or surgeons suggest liver transplant surgery to the patients who suffer from severe Drug-induced liver injury (DILI) or Chronic liver failure. This surgery carries a risk of other complications including infection, liver inflammation, blood clots, liver rejection, and memory thinking problems.

Track 16: Esophageal diseases

The esophagus is the solid cylinder that conveys nourishment and fluids from your mouth to the stomach. You may not be aware of your esophagus until you swallow something excessively enormous, excessively hot, or excessively cold. You may likewise see it when something isn't right. You may feel torment or experience difficulty gulping. The most well-known issue with the throat is GERD (gastroesophageal reflux disease). With GERD, a muscle at the end of your esophagus doesn't close appropriately. This permits stomach contents to spill back, or reflux, into the throat and aggravate it. After some time, GERD can make harm the throat. Different issues incorporate acid reflux, malignant growth, and eosinophilic esophagitis. Specialists may utilize different tests to make a diagnosis. These include imaging tests, an upper endoscopy, and a biopsy. Treatment relies upon the issue; a few issues improve with over-the-counter medications or changes in diet. Others may require physician recommended medicines or medical procedure.

Track 17:Colerectal and Intestinal diseases

Gastrointestinal maladies allude to sicknesses including the gastrointestinal tract, to be specific the throat, stomach, small digestive tract, internal organ and rectum, and the adornment organs of ingestion, the liver, gallbladder, and pancreas. Gastrointestinal issue incorporates such conditions as obstructing, irritable inside clutter, hemorrhoids, butt-centric gaps, perianal abscesses, butt-centric fistulas, perianal contaminations, diverticular sicknesses, colitis, colon polyps and infection. Enormous quantities of these can be envisioned or constrained by keeping up a sound lifestyle, practicing extraordinary entrail inclinations, and submitting to tumor screening.

Track 18:Hepato-pancreato-biliary disease

Hepato-pancreato-biliary disease alludes to any condition that influences the liver, pancreas, gallbladder, and the bile ducts. These ailments usually share some indications or side effects, for example, jaundice, darker urine colour, and lighter stool colour. While some have hereditary or inherited causes, most are because of chronic damage to the tissues of the organs involved. These conditions are dealt with and managed by hepatologists, hepato-pancreato-biliary oncologists, and transplant specialists

Track 19:Gastrointestinal Bleeding and Pathology

Gastrointestinal bleeding is one of the essential complaints of the patients which could be interminable, mellow or deadly. Most of the conditions, GI bleeding are contained without anyone else's input, yet they are are anyway evaluated to keep up a strategic distance from a repeat and to stay away from advance movement of sickness, expecting any. Gastrointestinal pathology (including liver, gallbladder and pancreas) is a perceived sub-specialty discipline of surgical pathology. Acknowledgment of a sub-specialty is commonly identified with dedicated fellowship training offered within the subspecialty or, on the other hand, to surgical pathologists with an extraordinary intrigue and broad involvement with gastrointestinal pathology. The gastrointestinal (GI) pathology decides quality indicative histopathology on gastrointestinal endoscopic biopsies and resections of the gastrointestinal and pancreatico-biliary systems

Track 20:Therapeutic and Diagnostic gastroenterology

Therapeutic and Diagnostic Gastroenterology provides a full range of advanced diagnostic and therapeutic endoscopic procedures which includes diagnostic and therapeutic ERCP for pancreatitis pathologies (papillotomy, stone extraction, stricture dilation and stenting, lithotripsy, peroral choledochoscopy and pancreatoscopy), endoscopic ultrasonography which include fine needle aspiration cytology and biopsy and target treatment. Other advanced methods including therapy for Barrett’s esophagus and early cancer including radiofrequency ablation, cyrotherapy and endoscopic mucosal resection. A portion of these diagnostic tools must be sterilized before using since they go about way for infection transmission

Hepatology, traditionally considered a sub-specialty of gastroenterology, is the branch of internal medicine that incorporates the study of liver, biliary tree, gallbladder and pancreas as well as management of disease and disorders associated with them. Some of the cases in hepatology include jaundice, liver cancer, liver transplantation, drug overdose, bilary infection bleeding, pancreatitis, GIT bleeding, etc. Although there is a reduction in deaths due to gallstone disease and gallbladder cancer, liver-related mortality has remained relatively stable over the last 30 years. Hepatology represents a growing problem for the international health care systems and first of all, for the patients. Alcoholism and the alcoholic liver disease resulting from it, is a remarkable factor in some Asian countries and in most industrial countries but here the rapidly growing segment in hepatology is NASH (non-alcoholic steatohepatitis). NASH is the major form of NAFLD, the major cause of cryptogenic liver cirrhosis. Nearly 10% of the US Americans (25 Million) suffer with liver-related diseases every year. Chronic liver diseases are the major problem. An estimated 30% of the world's overall population (2 billion) has been infected with hepatitis B virus and more than 350 million people are Inflicted by chronic HBV. About 170 million people have hepatitis C. Global Liver Disease Treatment Market is foreseen to collect $19,536 million by 2022, registering a CAGR of 11.72% during the forecast period 2016 - 2022. Additionally, according to the reports of American Cancer Society, liver cancer rates raises 2.7% each year driving the growth of market.

Scope

This conference unleashes the novel ideas and advanced diagnostic approaches towards the diseases associated to liver. The recent advancements and knowledge about liver and pancreatic diseases and the treatment strategies will be shared. The participant companies can gain the networks and promote their upcoming strategies by exhibitting their products at the conference.

The major intention of this conference is to bring together the Hepatologists, Gastroenterologists, Pathologists, Directors/CEO & Industry experts, Professors, Scientists, Researchers and Students of Hepatology in all areas of Liver diseases & Therapeutics and to provide an international forum for the exposure and dissemination of original research results, novel ideas and practical development experiences related to the research.

Association of Hepatology

The Japan Society of Hepatology

The Asian Pacific Association for the Study of the Liver [APASL]

Hepatology Society of the Philippines

European Association for the Study of the Liver (EASL)

International Liver Cancer Association

American Association for the Study of Liver Diseases (AASLD)

The International Association for the Study of the Liver

Emirates Gastroenterology and Hepatology Society (EGHS)

The Egyptian Society of Hepatology, Gastroenterology and Infectious Diseases in Alexandria (ESHGID)

The 43rd European Society For Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 14-15, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

7^th International Conference on Hepatology June 14-15, 2021 Osaka, Japan

Recommended Global Gastroenterology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

HEPATOLOGY-2021

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues